tiprankstipranks

Christopher Kemmerer Insider Profile

4 Followers
Christopher Kemmerer, VP, Pharma Dev & Manufacturing at Evofem Biosciences, holds 10.85K shares in Evofem Biosciences (Ticker: EVFM).
tipranks
Christopher Kemmerer

Christopher Kemmerer
Evofem Biosciences (EVFM)
VP, Pharma Dev & Manufacturing

Not Ranked
Christopher Kemmerer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$163
100.00%
A breakdown of Christopher Kemmerer's holdings

Insider Roles

Evofem Biosciences
(EVFM)
VP, Pharma Dev & Manufacturing
Roles that Christopher Kemmerer holds in companies

Most Profitable Insider Trade

Stock:
Evofem Biosciences
(EVFM)
Rating:Informative Buy
Date:Jun 16, 2015 - Jun 16, 2016
Return:-82.90%
The most profitable trade made by Christopher Kemmerer

Christopher Kemmerer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Evofem Biosciences
Sep 21, 2015
VP, Pharma Dev & Manufacturing
Uninformative Sell
12.19K
$162.72
Success Rate for
EVFM
0 out of 1 profitable transactions on
EVFM
0%
Average Return for
EVFM
Average return per transaction on
EVFM
-82.90%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 16, 2015
Informative Buy
$13.23K
-
$1.22
-82.90%
Aug 10, 2015
Uninformative Sell
$12.88K
-
$1.22
Sep 21, 2015
Uninformative Sell
$12.19K
-
$1.34
List of latest transactions for each holding click on a transaction to see Christopher Kemmerer's performance on stock

Christopher Kemmerer insider profile FAQ

What is the percentage of profitable transactions made by Christopher Kemmerer?
The percentage of profitable transactions made by Christopher Kemmerer is ―.
    What is the average return per transaction made by Christopher Kemmerer?
    The average return per transaction made by Christopher Kemmerer is ―.
      What stocks does Christopher Kemmerer hold?
      Christopher Kemmerer holds: EVFM stocks.
        What was Christopher Kemmerer’s latest transaction?
        Christopher Kemmerer latest transaction was an Uninformative Sell of $12.19K.
          What was Christopher Kemmerer's most profitable transaction?
          Christopher Kemmerer’s most profitable transaction was an Informative Buy of EVFM stock on June 16, 2015. The return on the trade was -82.90%.
            What is Christopher Kemmerer's role in Evofem Biosciences?
            Christopher Kemmerer's role in Evofem Biosciences is VP, Pharma Dev & Manufacturing.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.